Beauty Health Co
Qualité des données : 100%
SKIN
Nasdaq
Manufacturing
Measuring & Analyzing Instruments
0,92 €
▼
0,01 €
(-0,74%)
Cap. Boursière: 118,18 M
Prix
0,92 €
Cap. Boursière
118,18 M
Fourchette du Jour
0,90 € — 0,94 €
Fourchette 52 Semaines
0,76 € — 2,69 €
Volume
164 036
Ouverture 0,90 €
Moyenne 50J / 200J
1,13 €
18,41% below
Moyenne 50J / 200J
1,57 €
41,21% below
Quick Summary
Points Clés
Revenue grew 3,70% annually over 5 years — modest growth
Debt/Equity of 5,53 — high leverage
Generating 37,18 M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 13,72%
Capital efficient — spends only 0,10% of revenue on capex
Croissance
Revenue Growth (5Y)
3,70%
Au-dessus de la moyenne du secteur (1,82%)
Revenue (1Y)-10,02%
Earnings (1Y)N/A
FCF Growth (3Y)44,02%
Qualité
Return on Equity
-13,63%
Au-dessus de la moyenne du secteur (-53,41%)
ROIC-3,69%
Net Margin-3,16%
Op. Margin-6,92%
Sécurité
Debt / Equity
5,53
Au-dessus de la moyenne du secteur (0,31)
Current Ratio4,98
Interest Coverage-1,08
Valorisation
PE (TTM)
-12,41
En dessous de la moyenne du secteur (-1,48)
P/B Ratio1,80
EV/EBITDAN/A
Dividend YieldN/A
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -12,4 | -1,5 |
| P/B | 1,8 | 1,6 |
| ROE % | -13,6 | -53,4 |
| Net Margin % | -3,2 | -41,5 |
| Rev Growth 5Y % | 3,7 | 1,8 |
| D/E | 5,5 | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -10,02% | Revenue Growth (3Y) | -13,06% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 3,70% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 300,79 M | Net Income (TTM) | -9,52 M |
| ROE | -13,63% | ROA | -1,88% |
| Gross Margin | 65,28% | Operating Margin | -6,92% |
| Net Margin | -3,16% | Free Cash Flow (TTM) | 37,18 M |
| ROIC | -3,69% | FCF Growth (3Y) | 44,02% |
| Safety | |||
| Debt / Equity | 5,53 | Current Ratio | 4,98 |
| Interest Coverage | -1,08 | Asset Turnover | 0,59 |
| Working Capital | 246,46 M | Tangible Book Value | -98,82 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -12,41 | Forward P/E | N/A |
| P/B Ratio | 1,80 | P/S Ratio | 0,39 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 31,46% | ||
| Market Cap | 118,18 M | Enterprise Value | 481,57 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,16 | Revenue / Share | 2,35 |
| FCF / Share | 0,29 | OCF / Share | 0,29 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0,10% | FCF Conversion | -390,61% |
| SBC-Adj. FCF | 18,23 M | Growth Momentum | -13,72 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 300,79 M | 334,29 M | 397,99 M | 365,88 M | — |
| Net Income | -9,52 M | -29,10 M | -100,12 M | 44,38 M | -1,11 M |
| EPS (Diluted) | -0,16 | -0,36 | -0,76 | -0,23 | — |
| Gross Profit | 196,36 M | 182,30 M | 155,11 M | 250,34 M | — |
| Operating Income | -20,80 M | -67,77 M | -130,92 M | -24,28 M | -1,21 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 5,63 M | 6,30 M | 10,10 M | 8,44 M | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | 19,33 M | 10,41 M | 13,65 M | — | — |
| Income Tax | 3,58 M | -452 000,0 | -1,77 M | 648 000,0 | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 499,80 M | 685,68 M | 929,11 M | 1,01 B | 464,00 M |
| Total Liabilities | 438,75 M | 633,88 M | 869,72 M | 837,43 M | 16,87 M |
| Shareholders' Equity | 61,06 M | 51,80 M | 59,39 M | 171,48 M | 5,00 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | — | — | 523,03 M | 568,20 M | 3,27 M |
| Current Assets | 309,52 M | 477,12 M | 698,25 M | 789,10 M | 3,90 M |
| Current Liabilities | 186,28 M | 68,15 M | 115,01 M | 73,12 M | 765 497,0 |
{"event":"ticker_viewed","properties":{"ticker":"SKIN","listing_kind":"stock","pathname":"/stocks/skin","exchange":"Nasdaq","country":"US"}}

